Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 73.90B | 70.65B | 82.50B | 102.67B | 68.37B | 63.61B |
Gross Profit | 37.85B | 37.88B | 33.59B | 4.72B | 19.08B | 21.60B |
EBITDA | 22.84B | 22.02B | 19.39B | 20.11B | 16.40B | 14.95B |
Net Income | 6.30B | 7.02B | 3.44B | 1.68B | 3.19B | 2.61B |
Balance Sheet | ||||||
Total Assets | 179.44B | 187.14B | 195.22B | 219.62B | 206.94B | 163.45B |
Cash, Cash Equivalents and Short-Term Investments | 7.90B | 8.19B | 11.33B | 24.79B | 11.02B | 6.37B |
Total Debt | 65.63B | 70.35B | 73.56B | 87.91B | 70.92B | 58.66B |
Total Liabilities | 130.03B | 137.97B | 150.12B | 177.54B | 164.60B | 121.10B |
Stockholders Equity | 34.46B | 33.73B | 25.20B | 28.66B | 29.65B | 28.32B |
Cash Flow | ||||||
Free Cash Flow | 4.93B | 4.29B | 1.85B | -4.57B | -2.13B | 1.96B |
Operating Cash Flow | 12.92B | 13.22B | 14.62B | 8.67B | 10.07B | 11.51B |
Investing Cash Flow | -8.66B | -4.11B | -10.61B | -13.63B | -10.88B | -10.12B |
Financing Cash Flow | -10.35B | -7.99B | -8.36B | 7.37B | 3.78B | -3.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | €3.48B | 11.33 | 9.99% | 4.73% | 13.50% | 19.36% | |
69 Neutral | €7.32B | 8.84 | 16.17% | 4.31% | 2.73% | 6.02% | |
68 Neutral | €5.71B | 11.20 | 13.98% | 3.84% | 16.50% | 24.03% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
64 Neutral | €86.73B | 13.76 | 23.70% | 5.20% | -7.02% | 24.33% | |
63 Neutral | €4.36B | 11.27 | 14.47% | 4.65% | -15.52% | 19.61% |